Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Ceradyne
So what: Revenue fell 10% from a year ago to $130.6 million, even lower than the decline to $132.1 million analysts had expected. Net income was $6.8 million, just over one-third what it was a year ago, and the $0.28 per share in earnings was $0.06 below estimates.
Now what: Ceradyne's revenue and profits are heading in the wrong direction, making even its 7.9 trailing P/E ratio fail to look like a value. Management is expecting results to be similar to what it reported in the first half of the year unless solar or defense picks up. With the economy in the rough shape it is, there are better bets than a company that has declining earnings and relies on two industries under heavy cost pressure right now. I'll pass on the sale today.
Interested in more info on Ceradyne? Add it to your Watchlist.
Fool contributor Travis Hoium has no position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings, or follow his CAPS picks at TMFFlushDraw.
The Motley Fool owns shares of Ceradyne. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days. The Motley Fool has a disclosure policy.